Flow cytometric analysis of STAT5 phosphorylation and CD95 expression in CD4 + T lymphocytes treated with recombinant human erythropoietin

Journal of Receptors and Signal Transduction

Volumn 31, Issue 3, 2011, Pages 241-246

  Lisowska, Katarzyna A ^a   Dȩbska Ślizień, Alicja ^a   Jasiulewicz, Aleksandra ^a   Jóźwik, Agnieszka ^a   Rutkowski, Bolesław ^a   Bryl, Ewa ^a   Witkowski, Jacek M ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

apoptosis; EPO R; signal transduction; T lymphocytes

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; FAS ANTIGEN; INTERLEUKIN 2; STAT5 PROTEIN;

ADULT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL SURFACE; CHRONIC KIDNEY FAILURE; ERYTHROPOIESIS; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN EXPERIMENT; MONOCYTE; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE;

ADULT; ANTIGENS, CD95; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; ERYTHROPOIETIN; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; PHOSPHORYLATION; RECEPTORS, ERYTHROPOIETIN; STAT5 TRANSCRIPTION FACTOR;

EID: 79957862143     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2011.578646     Document Type: Article

References (27)

1. Stopka T, Zivny JH, Stopkova P, Prchal JF, Prchal JT. Human hematopoietic progenitors express erythropoietin. Blood 1998, 91, 3766-3772. (Pubitemid 28225744)
2. Lisowska KA, Debska-Slizien A, Bryl E, Rutkowski B, Witkowski JM. Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment. Artif Organs 2010, 34, 654-662.
3. Ihle JN. Cytokine receptor signalling. Nature 1995, 377, 591-594.
4. Sela S, Shurtz-Swirski R, Sharon R, Manaster J, Chezar J, Shkolnik G, Shapiro G, Shasha SM, Merchav S, Kristal B. The polymorphonuclear leukocyte-a new target for erythropoietin. Nephron 2001, 88, 205-210. (Pubitemid 32623482)
5. Takeshita A, Shinjo K, Higuchi M, Miyawaki S, Takemoto Y, Kishimoto Y, Saito K, Takuchi H, Kuriyama K, Kimura Y, Asou N, Takahashi M, Hotta T, Kanamaru A, Ueda R, Ohno R. Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study Group. Br J Haematol 2000, 108, 55-63. (Pubitemid 30089933)
6. Herbelin A, Nguyen AT, Zingraff J, Urea P, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 1990, 37, 116-125. (Pubitemid 20023775)
7. Cavaillon JM, Poignet JL, Fitting C, Delons S. Serum interleukin-6 in long-term hemodialyzed patients. Nephron 1992, 60, 307-313.
8. Kurz P, Köhler H, Meuer S, Hütteroth T, Meyer zum Büschenfelde KH. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int 1986, 29, 1209-1214. (Pubitemid 16094235)
9. Bryl E, Mysliwska J, Debska-Slizien A, Trzonkowski P, Rachon D, Bullo B, Zdrojewski Z, Mysliwski A, Rutkowski B. Recombinant human erythropoietin stimulates production of interleukin 2 by whole blood cell cultures of hemodialysis patients. Artif Organs 1999, 23, 809-816. (Pubitemid 29449112)
10. Bryl E, Mysliwska J, Debska-Slizien A, Rachon D, Bullo B, Lizakowski S, Mysliwski A, Rutkowski B. The influence of recombinant human erythropoietin on tumor necrosis factor alpha and interleukin-10 production by whole blood cell cultures in hemodialysis patients. Artif Organs 1998, 22, 177-181. (Pubitemid 28117545)
11. Lisowska KA, Debska-Slizien A, Radzka M, Witkowski JM, Rutkowski B, Bryl E. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes. Artif Organs 2010, 34, E77-E84.
12. Pallard C, Gouilleux F, Charon M, Groner B, Gisselbrecht S, Dusanter-Fourt I. Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells. J Biol Chem 1995, 270, 15942-15945.
13. Gilmour KC, Pine R, Reich NC. Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci USA 1995, 92, 10772-10776.
14. Klas C, Debatin KM, Jonker RR, Krammer PH. Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993, 5, 625-630. (Pubitemid 23209416)
15. Van Parijs L, Abbas AK. Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol 1996, 8, 355-361. (Pubitemid 26229657)
16. De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, Pelosi E, Riccioni R, Felli N, Samoggia P, Peschle C. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 1999, 93, 796-803. (Pubitemid 29067844)
17. Naranda T, Wong K, Kaufman RI, Goldstein A, Olsson L. Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site. Proc Natl Acad Sci USA 1999, 96, 7569-7574. (Pubitemid 29299703)
18. Karitskaia IA, Aksenov ND, Zenin VV, Khaidukova AL, Marakhova II. [Activation of transcriptional factors stat5 and stat3 during human T-lymphocyte proliferation induced by different mitogenic stimuli]. Tsitologiia 2006, 48, 42-49.
19. Pérez-Oliva JF, Casanova-González M, García- García I, Porrero-Martín PJ, Valenzuela-Silva CM, Hernández-Montero T, Lagarde-Ampudia M, Casanova-Kutsareva Y, Avila-Albuerne Y, Vargas-Batista A, Bobillo-López H, Herrera- Valdés R, López-Saura PA; Bioequivalence Study of Erythropoietin Group. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study. BMC Nephrol 2005, 6, 5.
20. Cheng J, Liu C, Koopman WJ, Mountz JD. Characterization of human Fas gene. Exon/intron organization and promoter region. J Immunol 1995, 154, 1239-1245.
21. Sae-Ung N, Matsushima T, Choi I, Abe Y, Winichagoon P, Fucharoen S, Nawata H, Muta K. Role of NF-kappa B in regulation of apoptosis of erythroid progenitor cells. Eur J Haematol 2005, 74, 315-323. (Pubitemid 40461152)
22. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 1993, 178, 2231-2235. (Pubitemid 23344883)
23. Kennedy NJ, Kataoka T, Tschopp J, Budd RC. Caspase activation is required for T cell proliferation. J Exp Med 1999, 190, 1891-1896.
24. Halupa A, Chohan M, Stickle NH, Beattie BK, Miller BA, Barber DL. Erythropoietin receptor Y479 couples to ERK1/2 activation via recruitment of phospholipase Cgamma. Exp Cell Res 2005, 309, 1-11. (Pubitemid 41191218)
25. Mayeux P, Dusanter-Fourt I, Muller O, Mauduit P, Sabbah M, Druker B, Vainchenker W, Fischer S, Lacombe C, Gisselbrecht S. Erythropoietin induces the association of phosphatidylinositol 3'-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor. Eur J Biochem 1993, 216, 821-828. (Pubitemid 23284127)
26. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16, 225-260. (Pubitemid 28183365)
27. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997, 15, 707-747. (Pubitemid 27169297)